These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7647220)

  • 1. Relative roles of tissue factor pathway inhibitor and antithrombin in the control of thrombogenesis.
    Abildgaard U
    Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S45-9. PubMed ID: 7647220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor pathway inhibitor (TFPI)--an update.
    Sandset PM
    Haemostasis; 1996 Oct; 26 Suppl 4():154-65. PubMed ID: 8979119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor: structure, biology and involvement in disease.
    Lwaleed BA; Bass PS
    J Pathol; 2006 Feb; 208(3):327-39. PubMed ID: 16261634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disseminated intravascular coagulation: antithrombin III and heparin].
    Thaler E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):740-50. PubMed ID: 75143
    [No Abstract]   [Full Text] [Related]  

  • 6. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological function of tissue factor pathway inhibitor and interaction with heparins.
    Sandset PM; Bendz B; Hansen JB
    Haemostasis; 2000; 30 Suppl 2():48-56. PubMed ID: 11251341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
    Okugawa Y; Wada H; Noda T; Sakakura M; Nakasaki T; Watanabe R; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Nobori T; Shiku H
    Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin.
    Kijowski R; Hoppensteadt D; Walenga J; Borris L; Lassen MR; Fareed J
    Thromb Res; 1994 Apr; 74(1):53-64. PubMed ID: 8029808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex.
    Iversen N; Strekerud FG; Abildgaard U
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):591-8. PubMed ID: 11085278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant human tissue factor pathway inhibitor on thrombus formation and its in vivo distribution in a rat DIC model.
    Elsayed YA; Nakagawa K; Kamikubo YI; Enjyoji KI; Kato H; Sueishi K
    Am J Clin Pathol; 1996 Nov; 106(5):574-83. PubMed ID: 8929465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is tissue factor pathway inhibitor involved in the antithrombotic effect of heparins? Biochemical considerations.
    Ostergaard P; Nordfang O; Petersen LC; Valentin S; Kristensen H
    Haemostasis; 1993 Mar; 23 Suppl 1():107-11. PubMed ID: 8388348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action.
    Hansen JB; Sandset PM; Huseby KR; Huseby NE; Bendz B; Ostergaard P; Nordøy A
    Br J Haematol; 1998 Jun; 101(4):638-46. PubMed ID: 9674734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
    Levi M
    J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders.
    Kaiser B; Hoppensteadt DA; Fareed J
    Expert Opin Investig Drugs; 2001 Nov; 10(11):1925-35. PubMed ID: 11772296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
    Takahashi H; Sato N; Shibata A
    Thromb Res; 1995 Nov; 80(4):339-48. PubMed ID: 8585047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.
    Gando S; Kameue T; Morimoto Y; Matsuda N; Hayakawa M; Kemmotsu O
    Crit Care Med; 2002 Aug; 30(8):1729-34. PubMed ID: 12163784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.
    Hansen JB; Sandset PM
    Thromb Res; 1998 Aug; 91(4):177-81. PubMed ID: 9736420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M; Wada H; Nakasaki T; Hiyoyama K; Mori Y; Nishikawa M; Deguchi H; Deguchi K; Gabazza EC; Shiku H
    Am J Hematol; 1999 Feb; 60(2):94-8. PubMed ID: 9929099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.